Activity Name: Milwaukee Vascular Symposium 2026
 

Time: April 10th, 2026

We appreciate your time and effort in participating in this CME Course Evaluation Process. This evaluation is a pipeline to bring your voice to the leadership, instructors, and CME team. We value your voice and try our best to improve the quality of future activities.

Did you use this information for specific patient(s)?
What patient/health care problem recently challenged you, and you wish you knew more about?
Comments and Feedback on the learning experience, content, procedure, and instructors, etc.
As a result of my participation in this activity, I am better able to... 4 - Strongly Agree 3- Agree 2 - Somewhat Disagree 1- Strongly disagree
1234
Describe the diagnostic workup and treatment for multiple vascular compression syndromes.
Describe differences in outcomes for custom physician modified endograft (PMEG) and commercially available thoracoabdominal multibranch endografts.
Create an algorithm for embolization of complex endoleaks after infrarenal aortic endograft placement.
Describe options for management of complex tibial artery lesions.
The following speaker(s) demonstrated experiential knowledge of the topic 4 - Strongly Agree 3- Agree 2 - Somewhat Disagree 1- Strongly Disagree
1234
Robert A. Hieb, MD, RVT, FSIR
Peter J. Rossi, MD, FACS, DFSVS
Kaila Redifer, Tremblay, MD
Abby Rothstein, MD, FACS
Brian Lewis, MD, FACS
Paul L. Linsky, MD
Shahriar Alizadegan, MD, FACS
Benjamin Starnes, MD, FACS
Michael Malinowski, MD, FACS
Momo Jammeh, MD, FACS
Tina Marie Hathway, PA-C
Victoria Knutson, APNP
Kate Goelz, PA
Jorge Mascaro, MD, FRCS
William Butak, B.S.
Joseph Hart, MD, MHL, FACS
Mitchell Dyer, MD, MSc
Erin Buchanan, MD
R. Clem Darling III, MD FACS
Willam Rilling, MD, FSIR
Parag Patel, MD, MS, FSIR
Iftikhar Zaman, MBBS, FRCR
Thomas Carver, MD
Choose the option that best fits your evaluation of this activity: 4 - Strongly Agree 3- Agree 2 - Somewhat Disagree 1- Strongly Disagree
1234
The content provided a fair and balanced coverage of the topic
The content was free of commercial bias